Sen, E. S., & Ramanan, A. V. (2018). Juvenile idiopathic arthritis- associated uveitis. Best Practice and Research: Clinical Rheumatology, 31(4), 517-534. https://doi.org/10.1016/j.berh.2018.01.002

Pneumocystis Jirovecii Pneumonia as a Sequela of COVID-19Journal NLM Abbreviation: J Biomed Res Environ Sci Journal Website Link: https://www.jelsciences.com Topics Summation:

Eroglu DS et al. Behçet’s Syndrome Complicated with … Akt Rheumatol 2021; 46: 485–488 | © 2021. Thieme. All rights reserved. Introduction Behçet’s

Update on the Treatment of Giant Cell Arteritis and Polymyalgia RheumaticaUpdate on the Treatment of Giant Cell Arterit is and Polymyalgia Rheumatica KEYWORDS KEY POINTS

Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trialUniversity of Groningen

Successful Treatment of Giant Cell Arteritis with Tocilizumab: Report of 2 Cases with Review of the LiteratureAitisha and Fayad, J Arthritis 2015, S1 DOI: 10.4172/2167-7921.S1-006

Giant cell arteritis: new concepts, treatments and the unmet need that remainsThis is a repository copy of Giant cell arteritis: new concepts, treatments and the unmet need

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestationsClinical

Page 1/7 Tocilizumab May Be a Key in Therapy for Cytokine Release Syndrome in Older Patients With Severe Symptoms of COVID-19 Xu Lengnan  Beijing Hospital Liu Xin 

The French paediatric cohort of Castleman disease: a retrospective report of 23 patientsAbstract Background: Castleman disease (CD) is a rare non-malignant lymphoproliferation